Glensmith Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.00 M
as on 18-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.98 Cr
as on 18-07-2024
- Revenue -4.37%
(FY 2023)
- Profit -94.74%
(FY 2023)
- Ebitda -64.09%
(FY 2023)
- Net Worth 4.27%
(FY 2023)
- Total Assets 9.13%
(FY 2023)
About Glensmith Labs
The Corporate was formerly known as Yours Medicare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹11.98 Cr.
Manish Garg and Sanjay Gupta serve as directors at the Company.
- CIN/LLPIN
U24100DL2014PTC273104
- Company No.
273104
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Glensmith Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Garg  | Director | 15-Feb-2015 | Current |
| Sanjay Gupta | Director | 12-Nov-2014 | Current |
Financial Performance and Corporate Structure Insights of Glensmith Labs.
Glensmith Labs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.37% decrease. The company also saw a substantial fall in profitability, with a 94.74% decrease in profit. The company's net worth moved up by a moderate rise of 4.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glensmith Labs?
In 2023, Glensmith Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skymap Pharmaceuticals Private LimitedActive 18 years 5 monthsManish Garg and Sanjay Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Mar 2015 | ₹11.98 Cr | Open |
How Many Employees Work at Glensmith Labs?
Glensmith Labs has a workforce of 217 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glensmith Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glensmith Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
